Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Common Equity (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Common Equity for 16 consecutive years, with $408.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity fell 3.9% year-over-year to $408.1 million, compared with a TTM value of $408.1 million through Sep 2025, down 3.9%, and an annual FY2024 reading of $419.0 million, down 10.41% over the prior year.
  • Common Equity was $408.1 million for Q3 2025 at Cross Country Healthcare, down from $412.2 million in the prior quarter.
  • Across five years, Common Equity topped out at $467.7 million in Q4 2023 and bottomed at $173.7 million in Q1 2021.
  • Average Common Equity over 5 years is $386.5 million, with a median of $419.0 million recorded in 2024.
  • The sharpest move saw Common Equity surged 113.82% in 2022, then dropped 10.41% in 2024.
  • Year by year, Common Equity stood at $294.3 million in 2021, then skyrocketed by 53.43% to $451.5 million in 2022, then increased by 3.58% to $467.7 million in 2023, then decreased by 10.41% to $419.0 million in 2024, then dropped by 2.58% to $408.1 million in 2025.
  • Business Quant data shows Common Equity for CCRN at $408.1 million in Q3 2025, $412.2 million in Q2 2025, and $418.2 million in Q1 2025.